Please share your phone number so we can contact you to learn about your health complaint.
Humira (Adalimumab) is one of the most widely prescribed biologic therapies worldwide. It has transformed the treatment of autoimmune conditions by targeting TNF-α (Tumor Necrosis Factor alpha), a protein responsible for inflammation.
Humira (Adalimumab) is a biologic medication designed to treat chronic autoimmune diseases. By blocking TNF, Humira helps reduce inflammation, relieve pain, and prevent long-term damage to joints, skin, or the digestive tract.
Humira is prescribed for:
Rheumatoid arthritis: To reduce pain, swelling, and improve mobility.
Psoriasis: To manage chronic skin plaques.
Crohn’s disease & Ulcerative colitis: To reduce intestinal inflammation and symptoms.
Ankylosing spondylitis: To ease stiffness, pain, and improve spine flexibility.
Humira is available as a pre-filled syringe or injection pen, administered subcutaneously every two weeks or as directed by the physician. Injection sites are usually the thighs or abdomen to minimize irritation.
While effective, Humira may cause:
Redness or irritation at the injection site.
Upper respiratory tract infections (cold, sinus infections).
Headaches or dizziness.
Increased susceptibility to infections due to immune suppression.
Humira in Egypt is available in hospitals and specialized pharmacies. It is considered very expensive, but it is sometimes provided through insurance coverage or special patient programs.
Humira (Adalimumab) is a groundbreaking biologic drug that revolutionized the treatment of autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease. Despite its high price in Egypt, it remains a vital treatment option.
Contact the Macrocare team about starting treatment and booking a medical consultation.